Adeela Kamal

Hoofd Techniek/Wetenschap/O&O bij ACTINIUM PHARMACEUTICALS, INC.

Vermogen: 217 921 $ op 31-08-2026

Health Technology

Deze pagina is voorbehouden aan leden. Meld je aan of maak een account aan om verder te gaan.

Latest insider transactions

An executive increases exposure to an industrial stock

Sector rotation: insiders are more active on clean energy names

New regulatory filing published for executive transactions

Executive Management

Board of Directors

Audit Committee

Institutional Investors

Sell-side Analysts

2026 - Chairman of the Board

2022 - Chief Executive Officer

2018 - Chief Financial Officer

2012 - Strategy Committee Member